The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Ren Ken since 2016.
The trader's CIK number is 1490733.
At the time of the last reporting, Ren Ken was the CEO and Director of Casi Pharmaceuticals, Inc.. (stock ticker symbol CASI).
Also see all insider trading activities at Casi Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2016 | CASI | 15,000 | $10,875 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2016-01-19 | CASI | Buy | 15,000 | .72 | 10,875 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ren Ken (CEO and Director of Casi Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.